Challenges  	Challenges  	 NNS	O
in  	in  	 IN	O
multiple  	multiple  	 JJ	O
sclerosis 	sclerosis 	 NN	O
;  	;  	 :	O
how  	how  	 WRB	O
to  	to  	 TO	O
define  	define  	 VB	O
occurence  	occurence  	 VBN	O
of  	of  	 IN	O
progression  	progression  	 VBG	O
The  	The  	 DT	O
challenges  	challenges  	 NNS	O
in  	in  	 IN	O
MS  	MS  	 NNP	B-NP
are  	are  	 VBP	O
related  	related  	 VBN	O
to  	to  	 TO	O
number  	number  	 NN	O
of  	of  	 IN	O
controversies  	controversies  	 NNS	O
in  	in  	 IN	O
various  	various  	 JJ	O
aspects  	aspects  	 NNS	O
of  	of  	 IN	O
disease  	disease  	 NN	O
but  	but  	 CC	O
the  	the  	 DT	O
relationship  	relationship  	 NN	B-NP
between  	between  	 IN	O
relapses  	relapses  	 NN	O
and  	and  	 CC	O
disability  	disability  	 JJ	B-NP
progression 	progression 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
aspects  	aspects  	 NNS	O
of  	of  	 IN	O
MS  	MS  	 NNP	B-NP
as  	as  	 IN	O
an  	an  	 DT	O
inflammatory  	inflammatory  	 JJ	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
neurodegenerative  	neurodegenerative  	 JJ	B-NP
disease  	disease  	 NN	I-NP
are  	are  	 VBP	O
extremely  	extremely  	 RB	O
important  	important  	 JJ	O
because  	because  	 IN	O
of  	of  	 IN	O
its  	its  	 PRP$	O
implications  	implications  	 NNS	B-NP
on  	on  	 IN	O
prognosis  	prognosis  	 NN	O
and  	and  	 CC	O
therapy  	therapy  	 NN	O
of  	of  	 IN	O
MS 	MS 	 NNP	B-NP
.  	.  	 .	O
MS  	MS  	 NNP	B-NP
was  	was  	 VBD	O
classically  	classically  	 VBN	O
regarded  	regarded  	 VBN	O
as  	as  	 IN	O
white  	white  	 JJ	O
matter  	matter  	 NN	O
inflammatory  	inflammatory  	 JJ	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
while  	while  	 IN	O
disability  	disability  	 JJ	B-NP
progression 	progression 	 NN	I-NP
,  	,  	 ,	O
brain  	brain  	 NN	O
and  	and  	 CC	O
spinal  	spinal  	 JJ	B-NP
cord  	cord  	 NN	I-NP
atrophy  	atrophy  	 NNS	I-NP
were  	were  	 VBD	O
regarded  	regarded  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
consequence  	consequence  	 NN	O
of  	of  	 IN	O
global  	global  	 JJ	O
inflammation  	inflammation  	 NN	B-NP
of  	of  	 IN	I-NP
NAWM  	NAWM  	 NNP	I-NP
and  	and  	 CC	O
secondary  	secondary  	 JJ	B-NP
involvement  	involvement  	 NN	I-NP
of  	of  	 IN	O
grey  	grey  	 JJ	O
matter 	matter 	 NN	O
.  	.  	 .	O
More  	More  	 RBR	O
recent  	recent  	 JJ	O
histopathology  	histopathology  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
new 	new 	 JJ	O
,  	,  	 ,	O
modern  	modern  	 JJ	O
MRI  	MRI  	 NNP	B-NP
techniques  	techniques  	 NNS	I-NP
changed  	changed  	 VBD	O
this  	this  	 DT	O
view  	view  	 NN	O
in  	in  	 IN	O
MS  	MS  	 NNP	B-NP
as  	as  	 IN	O
a  	a  	 DT	O
prominent  	prominent  	 JJ	O
grey  	grey  	 NN	O
and  	and  	 CC	O
white  	white  	 JJ	O
matter  	matter  	 NN	B-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
Inflammatory  	Inflammatory  	 JJ	B-NP
demyelination  	demyelination  	 NN	I-NP
of  	of  	 IN	O
grey  	grey  	 JJ	O
matter  	matter  	 NN	O
occurs  	occurs  	 VBZ	O
early  	early  	 RB	O
in  	in  	 IN	O
MS  	MS  	 NNP	B-NP
sometimes  	sometimes  	 RB	O
even  	even  	 RB	O
before  	before  	 IN	O
occurrence  	occurrence  	 NN	O
of  	of  	 IN	O
white  	white  	 JJ	O
matter  	matter  	 NN	B-NP
lesions 	lesions 	 NNS	I-NP
.  	.  	 .	O
Inspite  	Inspite  	 NNP	B-NP
of  	of  	 IN	O
early  	early  	 JJ	O
therapy  	therapy  	 NN	O
of  	of  	 IN	O
MS  	MS  	 NNP	B-NP
with  	with  	 IN	O
immunomodulatory  	immunomodulatory  	 JJ	B-NP
drugs  	drugs  	 NNS	I-NP
disability  	disability  	 JJ	I-NP
progression  	progression  	 NN	I-NP
and  	and  	 CC	O
neurodegeneration  	neurodegeneration  	 NNS	B-NP
are  	are  	 VBP	O
still  	still  	 RB	O
important  	important  	 JJ	O
and  	and  	 CC	O
common  	common  	 JJ	O
part  	part  	 NN	O
of  	of  	 IN	O
MS  	MS  	 NNP	B-NP
pathogenesis 	pathogenesis 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
indicate  	indicate  	 NN	O
that  	that  	 IN	O
treatment  	treatment  	 NN	O
is  	is  	 VBZ	O
not  	not  	 RB	O
adequate  	adequate  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
predicted  	predicted  	 JJ	O
severity  	severity  	 NN	O
of  	of  	 IN	O
MS 	MS 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
perhaps  	perhaps  	 RB	O
to  	to  	 TO	O
the  	the  	 DT	O
basic  	basic  	 JJ	O
pathogenetic  	pathogenetic  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
in  	in  	 IN	O
MS 	MS 	 NNP	B-NP
.  	.  	 .	O
Beside  	Beside  	 IN	O
acute  	acute  	 JJ	O
clinical  	clinical  	 JJ	B-NP
symptoms 	symptoms 	 NNS	I-NP
,  	,  	 ,	O
conclusions  	conclusions  	 NNS	O
about  	about  	 IN	O
the  	the  	 DT	O
severity  	severity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
disease  	disease  	 NN	O
are  	are  	 VBP	O
reflection  	reflection  	 VBN	O
of  	of  	 IN	O
MRI  	MRI  	 NNP	B-NP
sensitivity  	sensitivity  	 NN	I-NP
to  	to  	 TO	O
detect  	detect  	 VB	O
focal  	focal  	 JJ	B-NP
WM  	WM  	 NN	I-NP
lesions  	lesions  	 NNS	I-NP
and  	and  	 CC	O
insensitivity  	insensitivity  	 JJ	B-NP
to  	to  	 TO	O
detect  	detect  	 VB	O
grey  	grey  	 JJ	O
matter  	matter  	 NN	B-NP
lesions  	lesions  	 NNS	I-NP
which  	which  	 WDT	O
correlate  	correlate  	 VBZ	O
better  	better  	 JJR	O
with  	with  	 IN	O
clinical  	clinical  	 JJ	B-NP
symptoms 	symptoms 	 NNS	I-NP
.  	.  	 .	O
All  	All  	 DT	O
presented  	presented  	 JJ	O
studies  	studies  	 NNS	O
and  	and  	 CC	O
evaluations  	evaluations  	 JJ	O
point  	point  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
necessity  	necessity  	 NN	O
of  	of  	 IN	O
changing  	changing  	 VBG	O
the  	the  	 DT	O
established  	established  	 JJ	O
diagnostic  	diagnostic  	 JJ	B-NP
evaluation  	evaluation  	 NN	I-NP
and  	and  	 CC	O
treatment  	treatment  	 NN	O
in  	in  	 IN	O
MS 	MS 	 NNP	B-NP
.  	.  	 .	O
At  	At  	 IN	O
the  	the  	 DT	O
earliest  	earliest  	 JJS	O
stage  	stage  	 NN	O
of  	of  	 IN	O
MS  	MS  	 NNP	B-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 RB	O
in  	in  	 RB	O
follow  	follow  	 VB	O
up  	up  	 RP	O
of  	of  	 IN	O
disease  	disease  	 NN	O
it  	it  	 PRP	O
would  	would  	 MD	O
be  	be  	 VB	O
necessary  	necessary  	 JJ	O
to  	to  	 TO	O
apply  	apply  	 VB	O
a  	a  	 DT	O
new  	new  	 JJ	O
MRI  	MRI  	 NNP	B-NP
techniques  	techniques  	 NNS	I-NP
more  	more  	 RBR	O
available  	available  	 JJ	O
for  	for  	 IN	O
clinical  	clinical  	 JJ	B-NP
practice  	practice  	 NN	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
DIR  	DIR  	 NNP	B-NP
brain  	brain  	 NN	I-NP
MR  	MR  	 NNP	I-NP
imaging  	imaging  	 NN	I-NP
at  	at  	 IN	O
3T  	3T  	 CD	O
because  	because  	 IN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
sensitivity  	sensitivity  	 NN	O
to  	to  	 TO	O
detect  	detect  	 VB	O
grey  	grey  	 JJ	O
matter  	matter  	 NN	B-NP
lesions 	lesions 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
patient  	patient  	 NN	O
with  	with  	 IN	O
present  	present  	 JJ	O
cortical  	cortical  	 NNS	B-NP
lesions  	lesions  	 VBP	I-NP
even  	even  	 RB	O
in  	in  	 IN	O
earliest  	earliest  	 JJS	O
stages  	stages  	 NNS	O
of  	of  	 IN	O
MS  	MS  	 NNP	B-NP
depending  	depending  	 VBG	O
on  	on  	 IN	O
severity  	severity  	 NN	O
of  	of  	 IN	O
grey  	grey  	 JJ	O
matter  	matter  	 NN	B-NP
involvement  	involvement  	 NN	I-NP
more  	more  	 RBR	O
efficacious  	efficacious  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
like  	like  	 IN	O
second  	second  	 JJ	O
or  	or  	 CC	O
even  	even  	 RB	O
third  	third  	 JJ	O
line  	line  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
should  	should  	 MD	O
start 	start 	 VB	O
.  	.  	 .	O
